African nations push plans to manufacture own Covid vaccines
Kenya’s President Uhuru Kenyatta visits Aspen Pharmacare, the South African-based subsidiary of Aspen, which manufactures and distributes the Johnson and Johnson Covid-19 vaccine. PHOTO | PSCU
As the world heads into the third year of the Covid-19 pandemic, health representatives globally are worried that the virus will outpace global effort to vaccinate large portions of the world population by the first half of 2022.
Despite initial commitments from the Covax global vaccine distribution mechanism to ship two billion doses by end of 2021, efforts have fallen short, with only about 1.45 billion doses expected by January.
